EichorEICHOR
Study identifier: NCT07512128 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: Not Yet Recruiting

Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Femoral Stenting (SKYWARD Trans-Femoral IDE [Investigational Device Exemption] Study)

Condition: Carotid Artery Calcification · Carotid Artery Diseases  ·  Sponsor: Shockwave Medical, Inc.

PhaseNA
Planned participants185
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Prospective, Multi-center, Single-arm Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Femoral stenting (SKYWARD Trans-Femoral IDE Study)

This description comes directly from the study's public registry record.

Talk to the study team

Danilo Romero  ·  510-279-4262  ·  DRomer28@its.jnj.com

Birgit Greschner  ·  510-279-4262  ·  BGreschn@its.jnj.com

Always discuss trial participation with your own doctor first.

Locations (25)

Pulse InstituteScottsdale, Arizona, United States
HCA HealthOne SwedishAurora, Colorado, United States
Ascension St. Vincent'sJacksonville, Florida, United States
Baptist Health Research InstituteJacksonville, Florida, United States
Ascension Sacred HeartPensacola, Florida, United States
Wellstar Kennestone HospitalMarietta, Georgia, United States
Willis-KnightonShreveport, Louisiana, United States
Mercy South HospitalSt Louis, Missouri, United States
University of Buffalo NeurosurgeryBuffalo, New York, United States
Mount SinaiNew York, New York, United States
St. Francis Hospital & Heart CenterRoslyn, New York, United States
NC Heart and VascularRaleigh, North Carolina, United States

+ 13 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →